Search research articles
Contact Us
Filters
Showing results (311-320 of 626) with videos related to
Page
of 63
Sort By:
Diabetes Technology & Therapeutics
|
June 1, 2006
Development and validation of the Economic Assessment of Glycemic Control and Long-Term Effects of diabetes (EAGLE) model
Elvira Mueller, Stefanie Maxion-Bergemann, Dmitry Gultyaev, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
December 7, 2010
The vitamin D analog, TX527, promotes a human CD4+CD25highCD127low regulatory T cell profile and induces a migratory signature specific for homing to sites of inflammation
Femke Baeke, Hannelie Korf, Lut Overbergh, et al.
Diabetes Care
|
April 20, 2021
A Randomized, Open-Label Comparison of Once-Weekly Insulin Icodec Titration Strategies Versus Once-Daily Insulin Glargine U100
Ildiko Lingvay, John B Buse, Edward Franek, et al.
Diabetes Technology & Therapeutics
|
November 28, 2025
A Phase 2 (2a) Randomized Trial of Iscalimab in Adolescents and Young Adults with New-Onset Type 1 Diabetes
Chantal Mathieu, Michelle Quinlan, Kristina Wagner, et al.
Diabetes
|
March 29, 2006
Survival benefits of intensive insulin therapy in critical illness: impact of maintaining normoglycemia versus glycemia-independent actions of insulin
Björn Ellger, Yves Debaveye, Ilse Vanhorebeek, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
June 21, 2012
Patients with Type 2 Diabetes Initiating Exenatide Twice Daily or Insulin in Clinical Practice: CHOICE Study
Stephan Matthaei, Matthew Reaney, Chantal Mathieu, et al.
Diabetologia
|
September 13, 2024
Metabolic health in people living with type 1 diabetes in Belgium: a repeated cross-sectional study
Astrid Lavens, Christophe De Block, Philippe Oriot, et al.
Diabetes, Obesity & Metabolism
|
August 31, 2021
Efficacy and safety of liraglutide in type 1 diabetes by baseline characteristics in the ADJUNCT ONE and ADJUNCT TWO randomized controlled trials
Thomas F Dejgaard, Bernt J von Scholten, Erik Christiansen, et al.
Diabetes, Obesity & Metabolism
|
April 21, 2020
Long-term efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (the DEPICT-2 study): 52-week results from a randomized controlled trial
Chantal Mathieu, Gottfried Rudofsky, Moshe Phillip, et al.
Transplantation
|
May 24, 2008
Late CD8+ T cell-dependent xenoantibody production in innate tolerant nude rats after hamster islet grafting but not after hamster heart grafting
Timothy Devos, Li Shengqiao, Conny Gysemans, et al.
Page
of 63
Search research articles
Search
Showing results (311-320 of 626) with videos related to
Sort By:
Page
of 63
Diabetes Technology & Therapeutics
|
June 1, 2006
Development and validation of the Economic Assessment of Glycemic Control and Long-Term Effects of diabetes (EAGLE) model
Elvira Mueller, Stefanie Maxion-Bergemann, Dmitry Gultyaev, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
December 7, 2010
The vitamin D analog, TX527, promotes a human CD4+CD25highCD127low regulatory T cell profile and induces a migratory signature specific for homing to sites of inflammation
Femke Baeke, Hannelie Korf, Lut Overbergh, et al.
Diabetes Care
|
April 20, 2021
A Randomized, Open-Label Comparison of Once-Weekly Insulin Icodec Titration Strategies Versus Once-Daily Insulin Glargine U100
Ildiko Lingvay, John B Buse, Edward Franek, et al.
Diabetes Technology & Therapeutics
|
November 28, 2025
A Phase 2 (2a) Randomized Trial of Iscalimab in Adolescents and Young Adults with New-Onset Type 1 Diabetes
Chantal Mathieu, Michelle Quinlan, Kristina Wagner, et al.
Diabetes
|
March 29, 2006
Survival benefits of intensive insulin therapy in critical illness: impact of maintaining normoglycemia versus glycemia-independent actions of insulin
Björn Ellger, Yves Debaveye, Ilse Vanhorebeek, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
June 21, 2012
Patients with Type 2 Diabetes Initiating Exenatide Twice Daily or Insulin in Clinical Practice: CHOICE Study
Stephan Matthaei, Matthew Reaney, Chantal Mathieu, et al.
Diabetologia
|
September 13, 2024
Metabolic health in people living with type 1 diabetes in Belgium: a repeated cross-sectional study
Astrid Lavens, Christophe De Block, Philippe Oriot, et al.
Diabetes, Obesity & Metabolism
|
August 31, 2021
Efficacy and safety of liraglutide in type 1 diabetes by baseline characteristics in the ADJUNCT ONE and ADJUNCT TWO randomized controlled trials
Thomas F Dejgaard, Bernt J von Scholten, Erik Christiansen, et al.
Diabetes, Obesity & Metabolism
|
April 21, 2020
Long-term efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (the DEPICT-2 study): 52-week results from a randomized controlled trial
Chantal Mathieu, Gottfried Rudofsky, Moshe Phillip, et al.
Transplantation
|
May 24, 2008
Late CD8+ T cell-dependent xenoantibody production in innate tolerant nude rats after hamster islet grafting but not after hamster heart grafting
Timothy Devos, Li Shengqiao, Conny Gysemans, et al.
Page
of 63